BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25112658)

  • 41. Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists.
    Furlan C; Arcangeli S; Avanzo M; Mirri MA; Munoz F; Giudici S; Perrone A; Amelio D; Tomio L; Draghini L; Deli AM; Pavanato G; Giuliano FM; Pontoriero A; Ciammella P; Navarria P; Iannalfi A; Buglione M; Guida C; Cammelli S; Iorio V; Cardinali M; Genovesi D; Barsacchi L; Balducci M; Bagnoli R; Berti F; Montesi G; Pasqualetti F; Bonome P; Santoni R; Doino D; Schirru P; Pinzi V; Borzillo V; Ferrarese F; Ferro M; Cicco L; Krengli M; Scoccianti S; Donato V
    Tumori; 2018 Dec; 104(6):466-470. PubMed ID: 28315510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
    Jalali R; Raut N; Arora B; Gupta T; Dutta D; Munshi A; Sarin R; Kurkure P
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):113-8. PubMed ID: 19647954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients.
    Seidel C; von Bueren AO; Bojko S; Hoffmann M; Pietsch T; Gielen GH; Warmuth-Metz M; Bison B; Kortmann RD; Kramm CM
    Strahlenther Onkol; 2018 Mar; 194(3):215-224. PubMed ID: 29022050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility of Salvage Re-irradiation With Stereotactic Radiotherapy for Recurrent Glioma Using CyberKnife.
    Adachi K; Hayashi K; Kagawa N; Kinoshita M; Sumida I; Akino Y; Shiomi H; Tamari K; Suzuki O; Hirayama R; Kijima N; Isohashi F; Seo Y; Otani K; Kishima H; Ogawa K
    Anticancer Res; 2019 Jun; 39(6):2935-2940. PubMed ID: 31177132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of re-irradiation for recurrent gliomas and validation of a prognostic score.
    Post CCB; Kramer MCA; Smid EJ; van der Weide HL; Kleynen CE; Heesters MAAM; Verhoeff JJC
    Radiother Oncol; 2019 Jan; 130():156-163. PubMed ID: 30446315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.
    Combs SE; Thilmann C; Edler L; Debus J; Schulz-Ertner D
    J Clin Oncol; 2005 Dec; 23(34):8863-9. PubMed ID: 16314646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment outcomes of radiotherapy for primary spinal cord glioma.
    Choi SH; Yoon HI; Yi S; Park JW; Cho J; Shin DA; Ha Y; Kim DS; Kim SH; Lee SK; Chang JH; Suh CO
    Strahlenther Onkol; 2019 Feb; 195(2):164-174. PubMed ID: 30203111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.
    Gabayan AJ; Green SB; Sanan A; Jenrette J; Schultz C; Papagikos M; Tatter SP; Patel A; Amin P; Lustig R; Bastin KT; Watson G; Burri S; Stea B
    Neurosurgery; 2006 Apr; 58(4):701-9; discussion 701-9. PubMed ID: 16575334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Timing of re-irradiation in recurrent high-grade gliomas: a single institution study.
    Zemlin A; Märtens B; Wiese B; Merten R; Steinmann D
    J Neurooncol; 2018 Jul; 138(3):571-579. PubMed ID: 29520609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gamma knife radiosurgery for recurrent gliomas.
    Sadik ZHA; Hanssens PEJ; Verheul JB; Beute GN; Te Lie S; Leenstra S; Ardon H
    J Neurooncol; 2018 Dec; 140(3):615-622. PubMed ID: 30191361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation.
    Bouffet E; Hawkins CE; Ballourah W; Taylor MD; Bartels UK; Schoenhoff N; Tsangaris E; Huang A; Kulkarni A; Mabbot DJ; Laperriere N; Tabori U
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1541-8. PubMed ID: 22245198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients: A single institutional study.
    Kakria A; Rawat S; Bhutani R; Gupta G; Devnani B; Wahi IK; Ahlawat P
    Asia Pac J Clin Oncol; 2015 Jun; 11(2):129-34. PubMed ID: 25132076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.
    Murphy ES; Rogacki K; Godley A; Qi P; Reddy CA; Ahluwalia MS; Peereboom DM; Stevens GH; Yu JS; Kotecha R; Suh JH; Chao ST
    Pract Radiat Oncol; 2017; 7(6):e391-e399. PubMed ID: 28666902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
    Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Using Smaller-Than-Standard Radiation Treatment Margins Does Not Change Survival Outcomes in Patients with High-Grade Gliomas.
    Guram K; Smith M; Ginader T; Bodeker K; Pelland D; Pennington E; Buatti JM
    Pract Radiat Oncol; 2019 Jan; 9(1):16-23. PubMed ID: 30195927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase II trial of conformal radiation therapy for pediatric low-grade glioma.
    Merchant TE; Kun LE; Wu S; Xiong X; Sanford RA; Boop FA
    J Clin Oncol; 2009 Aug; 27(22):3598-604. PubMed ID: 19581536
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reirradiation for recurrent malignant brain tumor with radiotherapy or proton beam therapy. Technical considerations based on experience at a single institution.
    Mizumoto M; Okumura T; Ishikawa E; Yamamoto T; Takano S; Matsumura A; Oshiro Y; Ishikawa H; Sakurai H; Tsuboi K
    Strahlenther Onkol; 2013 Aug; 189(8):656-63. PubMed ID: 23824106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.
    Shapiro LQ; Beal K; Goenka A; Karimi S; Iwamoto FM; Yamada Y; Zhang Z; Lassman AB; Abrey LE; Gutin PH
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):636-42. PubMed ID: 22765876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.